| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Halozyme Therapeutics, Inc. (HALO) have been net sellers, shedding 205,852 shares worth roughly $22.1M on balance. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. HALO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 767.8K | $84.45M | -60,000 | |
| Dir | 53.6K | $5.81M | -5,230 | |
| VP | 49.9K | $3.47M | - | |
| Dir | 40.4K | $4.15M | - | |
| CFO | 38.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Torley Helen59 | President and CEO | Sale+OE | 16,569 | $68.92 | $1,141,924.75 | -2.3% | +2.6% | - | |
| Nov 12, 2025 | Torley Helen59 | President and CEO | Sale+OE | 60,000 | $69.47 | $4,167,929.57 | -7.6% | +13.6% | - | |
| Nov 10, 2025 | Connaughton Bernadette49 | Director | Sell | 2,000 | $68.48 | $136,960.00 | -4.4% | +18.3% | - | |
| Nov 1, 2025 | Caudill Cortney | SVP, Chief Operating Officer | Sale+OE | 4,263 | $65.19 | $277,904.97 | -25.1% | +10.0% | - | |
| Oct 3, 2025 | Torley Helen59 | President and CEO | Sale+OE | 60,000 | $71.86 | $4,311,745.12 | -7.6% | +1.9% | +59.3% | |
| Oct 1, 2025 | Connaughton Bernadette49 | Director | Sell | 2,000 | $75.24 | $150,481.00 | -4.3% | -9.7% | +42.7% | |
| Sep 22, 2025 | Labrosse Nicole60 | SVP, Chief Financial Officer | Sell | 2,227 | $77.95 | $173,584.49 | -9.2% | -12.9% | +47.1% | |
| Sep 10, 2025 | Labrosse Nicole60 | SVP, Chief Financial Officer | Sale+OE | 20,000 | $75.71 | $1,514,267.12 | -45.1% | -18.4% | +41.2% | |
| Sep 4, 2025 | Torley Helen59 | President and CEO | Sale+OE | 60,000 | $74.08 | $4,444,626.29 | -7.6% | -11.9% | +50.1% | |
| Sep 2, 2025 | Connaughton Bernadette49 | Director | Sell | 4,000 | $73.68 | $294,736.24 | -7.9% | -7.1% | +49.5% |